paradise: Epidemiology of TB in Indonesia

TB prevalence surveys conducted in six provinces in 1983-1993 showed that the prevalence of tuberculosis in Indonesia, ranging between 0.2 â € "0.65%. Meanwhile, according to the Global Tuberculosis Control report issued by WHO in 2004, TB incidence rate in 2002 reached 555 000 cases (256 kasus/100.000 population), and 46% of them are thought to be new cases. Estimated prevalence, incidence and deaths from tuberculosis is based on the analysis of all available data, such as reporting of cases, the prevalence of infection and illness, illness duration, the proportion of smear positive cases, the number of patients who received treatment and who did not receive treatment, the prevalence and incidence of HIV , mortality and demography.
Currently TB Prevalence Survey was conducted GFATM funded by the National Institute for Health Research & Development (NIHRD) in cooperation with the National Tuberculosis Programme (NTP), and is in the process of completion. This survey collects data and sputum examination of 20,000 households in 30 provinces. This study will provide new data that can be used to update estimates of incidence and prevalence, in order to obtain a more accurate estimate of the tuberculosis problem.
From the data in 1997-2004 [Attachment: Table of Cases 1997-2004 Identification and Reporting Level 1995 â € "2000] saw an increase in reporting of cases since 1996. The most dramatic occurred in 2001, namely the level of reporting of TB cases increased from 43 to 81 per 100,000 population, and reporting of smear positive cases increased from 25 to 42 per 100,000 population. Meanwhile, based on age, TB incidence rates seen slowly moving toward older age groups (with a peak at 55-64 years), although this time the majority of cases still occur in the age group 15-64 years. [Attachment: Age Specific Rate Notification 2004]
Medication Immunity Dual (Multi Drug Resistance / MDR)Although current data on the drug immunity doubles / MDR in Indonesia is not yet available, but has prepared a survey to be conducted at the end of 2005. The data on this matter is considered important for several reasons:

      Indonesia is a high-burden countries, and are rapidly expanding the DOTS strategy, hence the baseline drug susceptibility data (DST) will be a monitoring tool and indicator of a very important program.

      Based on data from several areas, identification and treatment of TB through the Hospital reached 20-50% of smear positive cases, and so much more to the case of a negative smear. If it does not work with health centers, many patients are diagnosed by the hospital to have a high risk of treatment failure, and may cause immune drugs.

      Due to the absence of a national laboratory network with adequate standards and quality, generalization and quality of available data can not be determined.

Articles you may require / need :

Senin, 13 Desember 2010

Epidemiology of TB in Indonesia

Tidak ada komentar:

Posting Komentar